{"entity":{"type":"insider","cik":"0001405685","url":"/insider/0001405685","json_url":"/insider/0001405685.json","name":"RAPP MICHAEL","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":13,"first":"2011-06-01","last":"2021-09-14","span_basis":"filed_date"},"name_variants":[{"name":"RAPP MICHAEL","source":"filing","n_filings":13,"first_seen":"2011-06-01","last_seen":"2021-09-14"}],"transactions":[{"id":5141776,"accession":"0001104659-21-115280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-115280","line_url":"/filing/0001104659-21-115280#line-1","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Immunome Inc.","issuer_ticker":"IMNM","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25962.0,"shares_display":"25,962","price_per_share":19.96,"price_display":"19.96","price_state":"stated","total_value":518201.52,"total_display":"518,201.52","total_whole":"518,202","shares_owned_after":208742.0,"shares_owned_after_display":"208,742","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-14","scope":"insider"},{"id":4366068,"accession":"0001104659-21-114881","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-114881","line_url":"/filing/0001104659-21-114881#line-3","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Immunome Inc.","issuer_ticker":"IMNM","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15500.0,"shares_display":"15,500","price_per_share":17.85,"price_display":"17.85","price_state":"stated","total_value":276675.0,"total_display":"276,675.00","total_whole":"276,675","shares_owned_after":182780.0,"shares_owned_after_display":"182,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-13","scope":"insider"},{"id":4366064,"accession":"0001104659-21-114881","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-114881","line_url":"/filing/0001104659-21-114881","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Immunome Inc.","issuer_ticker":"IMNM","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30450.0,"shares_display":"30,450","price_per_share":18.18632512315271,"price_display":"18.19","price_state":"stated","total_value":553773.6,"total_display":"553,773.60","total_whole":"553,774","shares_owned_after":167280.0,"shares_owned_after_display":"167,280","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-09","filed_date":"2021-09-13","scope":"insider","n_lines":2},{"id":4616781,"accession":"0001104659-21-072620","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-072620","line_url":"/filing/0001104659-21-072620#line-3","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Immunome Inc.","issuer_ticker":"IMNM","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":18.94,"price_display":"18.94","price_state":"stated","total_value":43562.0,"total_display":"43,562.00","total_whole":"43,562","shares_owned_after":136830.0,"shares_owned_after_display":"136,830","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-05-26","scope":"insider"},{"id":4616777,"accession":"0001104659-21-072620","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-072620","line_url":"/filing/0001104659-21-072620#line-2","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Immunome Inc.","issuer_ticker":"IMNM","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19303.0,"shares_display":"19,303","price_per_share":18.32,"price_display":"18.32","price_state":"stated","total_value":353630.96,"total_display":"353,630.96","total_whole":"353,631","shares_owned_after":134530.0,"shares_owned_after_display":"134,530","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-25","filed_date":"2021-05-26","scope":"insider"},{"id":4616773,"accession":"0001104659-21-072620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-072620","line_url":"/filing/0001104659-21-072620#line-1","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Immunome Inc.","issuer_ticker":"IMNM","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31895.0,"shares_display":"31,895","price_per_share":18.38,"price_display":"18.38","price_state":"stated","total_value":586230.1,"total_display":"586,230.10","total_whole":"586,230","shares_owned_after":115227.0,"shares_owned_after_display":"115,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-26","scope":"insider"},{"id":2145727,"accession":"0001209191-20-054318","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-054318","line_url":"/filing/0001209191-20-054318#line-2","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Immunome Inc.","issuer_ticker":"IMNM","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":83332.0,"shares_display":"83,332","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":999984.0,"total_display":"999,984.00","total_whole":"999,984","shares_owned_after":638886.0,"shares_owned_after_display":"638,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-06","filed_date":"2020-10-08","scope":"insider"},{"id":6030750,"accession":"0001615774-18-004593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-18-004593","line_url":"/filing/0001615774-18-004593#line-1","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5885.0,"shares_display":"5,885","price_per_share":10.45,"price_display":"10.45","price_state":"stated","total_value":61498.25,"total_display":"61,498.25","total_whole":"61,498","shares_owned_after":1500000.0,"shares_owned_after_display":"1,500,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-31","scope":"insider"},{"id":6170021,"accession":"0001615774-18-003217","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-18-003217","line_url":"/filing/0001615774-18-003217#line-1","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":10.463,"price_display":"10.46","price_state":"stated","total_value":156945.0,"total_display":"156,945.00","total_whole":"156,945","shares_owned_after":1494115.0,"shares_owned_after_display":"1,494,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-02","filed_date":"2018-05-02","scope":"insider"},{"id":6599004,"accession":"0001615774-18-002065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-18-002065","line_url":"/filing/0001615774-18-002065#line-1","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.279,"price_display":"9.28","price_state":"stated","total_value":92790.0,"total_display":"92,790.00","total_whole":"92,790","shares_owned_after":1479115.0,"shares_owned_after_display":"1,479,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-22","filed_date":"2018-03-23","scope":"insider"},{"id":6642872,"accession":"0001615774-18-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-18-000031","line_url":"/filing/0001615774-18-000031#line-1","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":12.9898,"price_display":"12.99","price_state":"stated","total_value":194847.0,"total_display":"194,847.00","total_whole":"194,847","shares_owned_after":1469115.0,"shares_owned_after_display":"1,469,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider"},{"id":4624445,"accession":"0001615774-17-005848","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001615774-17-005848","line_url":"/filing/0001615774-17-005848#line-3","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25745.0,"shares_display":"25,745","price_per_share":9.9357,"price_display":"9.94","price_state":"stated","total_value":255794.5965,"total_display":"255,794.60","total_whole":"255,795","shares_owned_after":1454115.0,"shares_owned_after_display":"1,454,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-23","filed_date":"2017-10-23","scope":"insider"},{"id":4624440,"accession":"0001615774-17-005848","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001615774-17-005848","line_url":"/filing/0001615774-17-005848#line-2","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":9.7846,"price_display":"9.78","price_state":"stated","total_value":293538.0,"total_display":"293,538.00","total_whole":"293,538","shares_owned_after":1428370.0,"shares_owned_after_display":"1,428,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-20","filed_date":"2017-10-23","scope":"insider"},{"id":4624437,"accession":"0001615774-17-005848","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-17-005848","line_url":"/filing/0001615774-17-005848#line-1","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44255.0,"shares_display":"44,255","price_per_share":9.59,"price_display":"9.59","price_state":"stated","total_value":424405.45,"total_display":"424,405.45","total_whole":"424,405","shares_owned_after":1398370.0,"shares_owned_after_display":"1,398,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-19","filed_date":"2017-10-23","scope":"insider"},{"id":2090228,"accession":"0001144204-16-141808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-141808","line_url":"/filing/0001144204-16-141808#line-1","is_derivative":false,"issuer_cik":"0001405685","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001405685","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":15.85,"price_display":"15.85","price_state":"stated","total_value":158500.0,"total_display":"158,500.00","total_whole":"158,500","shares_owned_after":1354115.0,"shares_owned_after_display":"1,354,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-29","filed_date":"2016-12-29","scope":"insider"},{"id":4621148,"accession":"0001144204-13-055845","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-055845","line_url":"/filing/0001144204-13-055845#line-1","is_derivative":false,"issuer_cik":"0001399520","issuer_name":"COMMITTED CAPITAL ACQUISITION Corp","issuer_ticker":"CCAC","issuer_name_source":null,"issuer_url":"/issuer/0001399520","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":163056.0,"shares_display":"163,056","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":815280.0,"total_display":"815,280.00","total_whole":"815,280","shares_owned_after":1563198.0,"shares_owned_after_display":"1,563,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-16","filed_date":"2013-10-18","scope":"insider"},{"id":3012365,"accession":"0001144204-12-013085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-12-013085","line_url":"/filing/0001144204-12-013085#line-2","is_derivative":false,"issuer_cik":"0001399520","issuer_name":"COMMITTED CAPITAL ACQUISITION Corp","issuer_ticker":"CCAC","issuer_name_source":null,"issuer_url":"/issuer/0001399520","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director, Officer (President and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Chairman","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":1833985.0,"shares_owned_after_display":"1,833,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-05","scope":"insider"},{"id":3012362,"accession":"0001144204-12-013085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-013085","line_url":"/filing/0001144204-12-013085#line-1","is_derivative":false,"issuer_cik":"0001399520","issuer_name":"COMMITTED CAPITAL ACQUISITION Corp","issuer_ticker":"CCAC","issuer_name_source":null,"issuer_url":"/issuer/0001399520","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director, Officer (President and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Chairman","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10214.0,"shares_display":"10,214","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":1844199.0,"shares_owned_after_display":"1,844,199","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-05","scope":"insider"},{"id":9194890,"accession":"0001144204-11-033550","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-11-033550","line_url":"/filing/0001144204-11-033550#line-3","is_derivative":false,"issuer_cik":"0001399520","issuer_name":"COMMITTED CAPITAL ACQUISITION Corp","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001399520","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director, Officer (President and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Chairman","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2067189.0,"shares_display":"2,067,189","price_per_share":0.0036,"price_display":"0.00","price_state":"stated","total_value":7441.8804,"total_display":"7,441.88","total_whole":"7,442","shares_owned_after":2151561.0,"shares_owned_after_display":"2,151,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-27","filed_date":"2011-06-01","scope":"insider"},{"id":9194889,"accession":"0001144204-11-033550","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-11-033550","line_url":"/filing/0001144204-11-033550#line-2","is_derivative":false,"issuer_cik":"0001399520","issuer_name":"COMMITTED CAPITAL ACQUISITION Corp","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001399520","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director, Officer (President and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Chairman","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":236613.0,"shares_display":"236,613","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":1914948.0,"shares_owned_after_display":"1,914,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-27","filed_date":"2011-06-01","scope":"insider"},{"id":9194888,"accession":"0001144204-11-033550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-033550","line_url":"/filing/0001144204-11-033550#line-1","is_derivative":false,"issuer_cik":"0001399520","issuer_name":"COMMITTED CAPITAL ACQUISITION Corp","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001399520","owner_cik":"0001405685","owner_name":"RAPP MICHAEL","owner_display_name":"RAPP MICHAEL","owner_url":"/insider/0001405685","role":"Director, Officer (President and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Chairman","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19037.0,"shares_display":"19,037","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":1933985.0,"shares_owned_after_display":"1,933,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-27","filed_date":"2011-06-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":19,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001472012","name":"Immunome Inc.","url":"/issuer/0001472012","role":"Director","n_filings":4,"first_seen":"2020-10-08","last_seen":"2021-09-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001621443","name":"Zynerba Pharmaceuticals, Inc.","url":"/issuer/0001621443","role":"Ten percent owner","n_filings":6,"first_seen":"2016-12-29","last_seen":"2018-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001399520","name":"COMMITTED CAPITAL ACQUISITION Corp","url":"/issuer/0001399520","role":"Director, Officer (President and Chairman)","n_filings":3,"first_seen":"2011-06-01","last_seen":"2013-10-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001405685","retrieved_at":"2026-08-26T10:35:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}